Nonexercise Estimation of VO<sub>2</sub>peak Using Seismocardiography in Female Subelite and Male Elite Football Players
A novel method for estimating V̇O<sub>2</sub>peak using seismocardiography (SCG eV̇O<sub>2</sub>peak) at rest was developed some years ago, and this study investigates an updated version using data from a trained population. Forty five subelite female and Sixty seven elite male football players were tested and included in a cross-sectional accuracy comparison between SCG eV̇O<sub>2</sub>peak and V̇O<sub>2</sub>peak obtained from an incremental cardiopulmonary exercise test (CPET) performed on a treadmill. In addition, the ability of the method to detect changes over time was assessed by comparison of changes in V̇O<sub>2</sub>peak over 3 months (female and male, n = 60), 6 months (female, n = 17), and 1 year (male, n = 18) for CPET and SCG, respectively. No difference and a fair agreement were found between combined sex cross-sectional SCG eV̇O<sub>2</sub>peak and CPET V̇O<sub>2</sub>peak (bias ± 95% CI: -1.0 ± 0.9 mL·min<sup>-1</sup>·kg<sup>-1</sup> and limits of agreement [95%]: ± 9.1 mL·min<sup>-1</sup>·kg<sup>-1</sup>), with similar agreement between sexes. The standard error of estimation and mean absolute percentage error were 4.8 mL·min<sup>-1</sup>·kg<sup>-1</sup> and 7.4%, respectively. V̇O<sub>2</sub>peak was only increased over 6 months for females (CPET: 2.2 ± 1.1 mL·min<sup>-1</sup>·kg<sup>-1</sup>, SCG: 1.2 ± 1.1 mL·min<sup>-1</sup>·kg<sup>-1</sup>, and p < 0.05) with no difference between methods (p = 0.170). A correlation between ΔV̇O<sub>2</sub>peak for CPET and SCG was found for 1-year analyses (male, R<sup>2</sup> = 0.62, and P < 0.05) but no other correlations were significant. The SCG method is accurate in estimating V̇O<sub>2</sub>peak in both subelite and elite football players, with fair agreement and low estimation errors. The SCG method was able to detect an association of 1-year changes but not for changes over shorter times; however, these results require more investigation due to small sample sizes.
Authors
- Tue Rømer (ORCID: https://orcid.org/0000-0002-3037-9344)
- Mikkel Thunestvedt Hansen (ORCID: https://orcid.org/0000-0002-3879-2192)
- Malte Nejst Larsen (ORCID: https://orcid.org/0000-0002-2600-7126)
- Axel Illeris Poggi (ORCID: https://orcid.org/0000-0003-3978-9857)
- Bo Bernhard Nielsen
- Peter Krustrup (ORCID: https://orcid.org/0000-0002-1461-9838)
- Paweł Chmura (ORCID: https://orcid.org/0000-0002-4211-0393)
- Ronni Eg Sahl (ORCID: https://orcid.org/0000-0002-7276-2384)
- Jørn Wulff Helge (ORCID: https://orcid.org/0000-0001-9724-5423)
- Kristine Kjær Lange
- Kristoffer Furbo
- Jennie Brask Augsburg
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Novo Nordisk Foundation (DK)
- Odense Municipality (DK)
- Wroclaw University of Health and Sport Sciences (PL)
Publication Details
- Journal
- European Journal of Sport Science
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1002/ejsc.70047
- Primary Topic
- Non-Invasive Vital Sign Monitoring
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk
- Novo Nordisk Fonden